Browsing: GLP-1

Teva Pharmaceuticals has launched a generic version of Novo Nordisk’s Victoza, the first generic GLP-1 drug available in the United…

The vibrating capsule, likened to the feeling of drinking a glass full of water before eating, targets the brain’s perception of satiety. When ingested 20 minutes prior to a meal, it stimulates mechanoreceptors, which in turn signal the brain via the vagus cranial nerve. This signal initiates the production of hormones such as insulin, GLP-1, C-peptide, and PYY, reducing hunger and enhancing the digestion process. In animal models, this mechanism resulted in a reduction of food consumption by about 40%.

In the realm of healthcare and wellness, advancements in medical science continually push the boundaries of what is possible in managing chronic conditions. One such breakthrough in diabetes management is Ozempic.